Pacira BioSciences' Retained Earnings rose 963.95% to -$201.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$201.0 million, marking a year-over-year increase of 963.95%. This contributed to the annual value of -$206.4 million for FY2024, which is 9322.45% down from last year.
According to the latest figures from Q3 2025, Pacira BioSciences' Retained Earnings is -$201.0 million, which was up 963.95% from -$206.4 million recorded in Q2 2025.
Pacira BioSciences' Retained Earnings' 5-year high stood at -$78.9 million during Q2 2024, with a 5-year trough of -$243.5 million in Q1 2021.
Over the past 5 years, Pacira BioSciences' median Retained Earnings value was -$168.3 million (recorded in 2023), while the average stood at -$170.2 million.
In the last 5 years, Pacira BioSciences' Retained Earnings soared by 4461.92% in 2024 and then tumbled by 16148.28% in 2025.
Pacira BioSciences' Retained Earnings (Quarter) stood at -$211.9 million in 2021, then grew by 29.8% to -$148.8 million in 2022, then rose by 28.2% to -$106.8 million in 2023, then tumbled by 93.22% to -$206.4 million in 2024, then rose by 2.62% to -$201.0 million in 2025.
Its last three reported values are -$201.0 million in Q3 2025, -$206.4 million for Q2 2025, and -$201.5 million during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value